bilaterals.org logo
bilaterals.org logo

All articles


The model BIT: A framework for intellectual property agreements
Article from Infojustice about using the US Model BIT framework to create model IPR Agreements and chapters to increase the legitimacy of international policy making in this area....
Trade deal to curb generic-drug use
Some countries whose governments purchase drugs with a set budget are also alarmed by signs that the TPP may grant new negotiating powers to the industry.
Protesters: Free trade deals, drug patents derail AIDS fight
As the nineteenth International AIDS Conference continued in Washington Tuesday, thousands of protesters marched on the White House calling for an end to free trade deals that protesters argue make vital AIDS medicines unaffordable.
Access to medicines and intellectual property in Jordan
Delayed market entry of generics due to enhanced intellectual property protection cost Jordanian private consumers approximately 18 million US dollars annually
EU parliamentarians reject ACTA
The EU Parliament has rejected the controversial global Anti-Counterfeiting Trade Agreement. The decision is a victory for thousands of Europeans who took to the streets in furious protest against ACTA.
MEPs to ’finish off’ ACTA on 4 July
A European Parliament Committee rejected the Anti-Counterfeiting Trade Agreement (ACTA) yesterday despite pro-business lobbying by Trade Commissioner Karel De Gucht, who insisted that Parliament should not decide before the European Court of Justice gives its opinion. A final vote in the full Parliament is expected on 4 July.
Ensuring Free Trade Agreements don’t impede access to HIV treatments
The UN’s top agency for HIV-AIDS has warned that million of lives could be at risk, if intellectual property and other trade agreements impede access to treatment.
PIJIP trade agreement table updated: Compares TPP, ACTA, TRIPS, US-Chile FTA
New comparative analysis shows that TPP contains a plethora of TRIPS-plus provisions as well as ACTA-plus and Chile FTA-plus provisions.
TPP negotiators turn to pharmaceutical reimbursement
Negotiations of the Transpacific Partnership Agreement (TPP) have turned to discussions of the pharmaceutical reimbursement chapter. This issue is highly controversial and represents a very recent shift in US trade policy.
Bulgaria retracts support for global anti-piracy agreement ACTA
“Authors’ copyrights should not be placed above human rights,” Economy and Energy Minister Traicho Traikov said today,
ACTA opponents welcome Germany’s decision
Opponents of the Anti-Counterfeiting Trade Agreement (ACTA) welcomed the official decision by the German government today to wait for action from the European Parliament before signing the treaty, calling it a sign that the debate over the balance between copyright protection and Internet freedom has become more explicitly political.
Does EU/India free trade agreement spell the end of cheap drugs for poor countries?
After four years of negotiations, campaigners fear India is about to sign a trade deal with the EU which will stop the flow of cheap life-saving drugs to the developing world
ACTA and TPP: The new enemies of the World Wide Web
The Anti-Counterfeiting Trade Agreement (ACTA) and Trans-Pacific Partnership Agreement (TPP) are essentially an alteration to SOPA and PIPA for the rest of the world.
ACTA protests lead EU Governments to suspend endorsement of the text
Poland, Slovakia and the Czech Republic have announced that they will delay their endorsement of a controversial trade agreement following a tide of public protest.